Marbles Health launch of EASE 2.0, next generation of portable neuromodulation and EEG treatment ecosystem

Delhi-based startup Marbles Health has announced the launch of EASE 2.0, the next generation of its portable neuromodulation and electroencephalogram (EEG) treatment ecosystem. Priced at Rs 5 lakh per unit, EASE 2.0 is designed to help psychiatrists, neurologists, and rehabilitation specialists deliver a more measurable, monitored, and data-informed approach to brain health.

Where medication acts on brain chemistry, EASE works on the brain's electrical activity, rebalancing the dysregulated patterns that underlie depression, anxiety, OCD, and neuropsychiatric conditions. Unlike conventional brain stimulation devices that deliver stimulation without measuring how the brain responds, EASE 2.0 is a closed-loop ecosystem that combines treatment, measurement of brain activity, cognitive-emotional training, reporting, and clinician oversight within a single platform. 

Completely designed and manufactured in India, EASE 2.0 has been built in accordance with more than eight ISO/IEC medical electrical standards and is backed by one granted patent and three filed patents. It is also the only CDSCO-approved integrated neuromodulation and EEG treatment ecosystem in India. EASE 2.0 is currently accessible across India through top hospitals and clinics, while clinician-supervised at-home services are being offered in select metro cities.

While EASE 1.0 established the foundation for portable neuromodulation, EASE 2.0 significantly expands the platform's capabilities and clinical applications. The latest version is designed to support a broader range of conditions, including addiction, eating disorders, bipolar affective disorder (BPAD), and ADHD-related impulsivity.